Trial intelligence / Profile preview

Azithromycin for BPD Prevention in Preterm Infants

NCT05311228Phase 4Completed

Sponsor
Universitas Indonesia
Start
Jun 2021
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of azithromycin in bronchopulmonary dysplasia (BPD), sponsored by Universitas Indonesia. Started Jun 2021; status: completed.

02

Drugs

azithromycin
03

Conditions

bronchopulmonary dysplasia (BPD)

Beyond the preview

Go deeper on NCT05311228.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05311228.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call